Trends in financial payments from industry to US cancer centers, 2014-2021 Journal Article

   


Authors: Chakraborty, N.; Brown, M.; Persaud, S.; Gallagher, G.; Trivedi, N. U.; Bach, P. B.; Mitchell, A. P.
Article Title: Trends in financial payments from industry to US cancer centers, 2014-2021
Abstract: Background: Industry payments to US cancer centers are poorly understood. Methods: US National Cancer Institute (NCI)–designated comprehensive cancer centers were identified (n 1⁄4 51). Industry payments to NCI–designated comprehensive cancer centers from 2014 to 2021 were obtained from Open Payments and National Institutes of Health (NIH) grant funding from NIH Research Portfolio Online Reporting Tools (RePORT). Given our focus on cancer centers, we measured the subset of industry payments related to cancer drugs specifically and the subset of NIH funding from the NCI. Results: Despite a pandemic-related decline in 2020-2021, cancer-related industry payments to NCI–designated comprehensive cancer centers increased from $482 million in 2014 to $972 million in 2021. Over the same period, NCI research grant funding increased from $2 481 million to $2 724 million. The large majority of nonresearch payments were royalties and licensing payments. Conclusion: Industry payments to NCI–designated comprehensive cancer centers increased substantially more than NCI funding in recent years but were also more variable. These trends raise concerns regarding the influence and instability of industry payments. # The Author(s) 2024. Published by Oxford University Press.
Keywords: controlled study; united states; antineoplastic agent; cohort analysis; drug cost; financial management; cancer center; trend study; funding; national health organization; pandemic; teaching hospital; prospective payment; human; article; malignant neoplasm
Journal Title: JNCI Cancer Spectrum
Volume: 8
Issue: 3
ISSN: 2515-5091
Publisher: Oxford University Press  
Date Published: 2024-06-01
Start Page: pkae015
Language: English
DOI: 10.1093/jncics/pkae015
PUBMED: 38825338
PROVIDER: scopus
PMCID: PMC11144522
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195067358&doi=10.1093%2fjncics%2fpkae015&partnerID=40&md5=5ba5a15627c44fe114a75f643ae15b28
Notes: Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PDF -- MSK corresponding author is Aaron Mitchell -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Peter Bach
    255 Bach
  2. Aaron Philip Mitchell
    62 Mitchell
  3. Niti U Trivedi
    8 Trivedi
  4. Nirjhar Chakraborty
    9 Chakraborty
  5. Grace Boyan Gallagher
    19 Gallagher
  6. Sonia Persaud
    26 Persaud
Related MSK Work